Related Experiment Video

Updated: Aug 7, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 24, 2014

Update on therapeutic neovascularization

Yihai Cao1, An Hong, Henny Schulten

  • 1Laboratory of Angiogenesis Research, Microbiology and Tumor Biology Center, Karolinska Institutet, S-171 77 Stockholm, Sweden. yihai.cao@mtc.ki.se

Cardiovascular Research
|January 25, 2005
PubMed

Insights

Therapeutic neovascularization shows promise for cardiovascular ischemia. Future strategies may involve combinations of growth factors or cell therapies, or optimized single growth factor treatments for stable, functional vessels.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Angiogenesis Research

Background:

  • Therapeutic neovascularization for cardiovascular ischemia faces challenges despite early promise.
  • Understanding the pleiotropic effects of angiogenic cytokines is crucial.
  • Existing clinical trials have yielded disappointing results.

Purpose of the Study:

  • To review current understanding and future directions in therapeutic neovascularization.
  • To explore novel strategies beyond current clinical limitations.
  • To highlight the importance of preclinical data in guiding therapeutic development.

Main Methods:

  • Review of recent scientific literature on growth factors and pro-angiogenic strategies.
  • Analysis of emerging therapeutic approaches, including combination therapies and single growth factor treatments.
  • Discussion of gene therapy versus protein therapy considerations.

Main Results:

  • Emerging data suggest single growth factor therapy can yield stable, functional vessels with appropriate dosing and regimens.
  • Combination therapies (growth factors, cell transplants) show potential but increase study complexity.
  • Technical advancements in vector design and slow-release formulations are key.

Conclusions:

  • Future therapeutic neovascularization strategies require rational design based on fundamental and preclinical data.
  • Optimized single growth factor therapies and combination approaches warrant further investigation.
  • Gene or protein therapy optimization depends on technical progress.

More Related Videos

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model09:56

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...